Skip to content
Screener

Arcutis Biotherapeutics, Inc. ARQT EBITDA

EBITDA at other companies

Pfizer logo
PfizerPFE
$4.78B+8.6%
Amgen logo
AmgenAMGN
$4.63B+15.7%
Incyte logo
IncyteINCY
$724.37M+30.9%
PVL
Palvella TherapeuticsPVLA
-$1.79M—
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$79.72M-26.6%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$73.58M+10.8%

Other financials

Income statement

See full
Revenue$129.9M+59.3%
Gross profit$118.9M+60.7%
Operating income$16.4M+212%
Net income$15.0M+194%
EPS (diluted)$0.11+185%

Balance sheet

See full
Cash & equivalents$34.4M-52.9%
Total debt$114.1M+3.6%
Total equity$220.6M+58.7%
Total assets$488.5M+38.6%

Cash flow

See full
Operating cash flow$12.6M—
CapEx$158.0K+103%
Free cash flow$12.5M—

Valuation

See full
Market cap$3.32B+81.4%
Enterprise value$3.4B+82.1%
P/S7.2×+0.2×

Profitability

See full
Gross margin91.1%+2.0pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.5×-0.3×
Current ratio2.9×-0.3×

Where this comes from

Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.

$16.4Mebit+
$563.0KDepreciation Depletion & Amortization
=$16.99M

The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001787306-26-000051

FAQ

What is Arcutis Biotherapeutics, Inc.'s EBITDA?
Arcutis Biotherapeutics, Inc. (ARQT) reported EBITDA of $16.99M in Q2 2026.
How has Arcutis Biotherapeutics, Inc.'s EBITDA changed year-over-year?
Arcutis Biotherapeutics, Inc.'s EBITDA increased by 221.0% year-over-year, from -$14.05M to $16.99M.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s EBITDA?
Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s EBITDA has grown at a -15.2% compound annual growth rate (CAGR), from -$206.08M to -$125.79M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Arcutis Biotherapeutics, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude